Cidara Therapeutics logo

Cidara Therapeutics share price today

(CDTX)

Cidara Therapeutics share price is $26.88 & ₹2,302.27 as on 1 Jan 2025, 2.30 'hrs' IST

$26.88

1.63

(6.46%)

Market is closed - opens 8 PM, 02 Jan 2025

View live Cidara Therapeutics share price in Dollar and Rupees. Guide to invest in Cidara Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Cidara Therapeutics. Get details on the Indian mutual funds that are investing in Cidara Therapeutics. Get Analyst recommendations and forecasts along with all the Cidara Therapeutics's financials.

Cidara Therapeutics share price movements

  • Today's Low: $25.18
    Today's High: $27.39

    Day's Volatility :8.07%

  • 52 Weeks Low: $10.00
    52 Weeks High: $27.44

    52 Weeks Volatility :63.54%

Cidara Therapeutics Returns

PeriodCidara Therapeutics IncIndex (Russel 2000)
3 Months
151.21%
0.0%
6 Months
123.07%
0.0%
1 Year
71.58%
0.0%
3 Years
-3.31%
-21.2%

Cidara Therapeutics Key Statistics

in dollars & INR

Previous Close
$25.25
Open
$25.61
Today's High
$27.39
Today's Low
$25.18
Market Capitalization
$294.2M
Today's Volume
$183.3K
52 Week High
$27.44
52 Week Low
$10.004
Revenue TTM
$53.9M
EBITDA
$-30.1M
Earnings Per Share (EPS)
$-23.9
Profit Margin
-211.35%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-153.39%

How to invest in Cidara Therapeutics from India?

It is very easy for Indian residents to invest directly in Cidara Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cidara Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cidara Therapeutics or CDTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cidara Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cidara Therapeutics shares which would translate to 0.032 fractional shares of Cidara Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cidara Therapeutics, in just a few clicks!

Returns in Cidara Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cidara Therapeutics investment value today

Current value as on today

₹1,74,405

Returns

₹74,405

(+74.4%)

Returns from Cidara Therapeutics Stock

₹71,538 (+71.54%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Cidara Therapeutics

-29%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Cidara Therapeutics on INDmoney from India has reduced in the last 30 days as on Jan 2, 2025. -29% less investors are searching Cidara Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Cidara Therapeutics

  • RA Capital Management, LLC

    6.43%

  • Bain Capital Life Sciences Investors, LLC

    6.43%

  • Bvf Inc

    6.43%

  • Monashee Investment Management LLC

    3.37%

  • Checkpoint Capital LP

    1.67%

  • Vanguard Group Inc

    1.65%

Analyst Recommendation on Cidara Therapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cidara Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Cidara Therapeutics

What analysts predicted

Upside of 7.89%

Current:

$26.88

Target:

$29.00

Insights on Cidara Therapeutics

  • Price Movement

    In the last 7 days, CDTX stock has moved up by 15.8%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 17.58M → 302.0K (in $), with an average decrease of 74.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -89.41M → -15.53M (in $), with an average increase of 475.5% per quarter
  • CDTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 33.0%

Cidara Therapeutics Technicals Summary

Sell

Neutral

Buy

Cidara Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cidara Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cidara Therapeutics Inc
51.78%
123.07%
71.58%
-3.31%
-62.87%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-22.37%
13.59%
91.62%
Biontech Se
-1.42%
42.28%
3.53%
-50.85%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
23.43%
35.31%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-1.95%
80.96%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cidara Therapeutics Inc
NA
NA
0.0
-22.43
-1.53
-0.16
NA
-1.81
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cidara Therapeutics Inc
Buy
$294.2M
-62.87%
NA
-211.35%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Cidara Therapeutics

cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies. our first product candidate is cd101 iv, a potential once-weekly intravenous therapy being developed for the treatment and prevention of systemic fungal infections. our second product candidate, cd101 topical, is a topical formulation of cd101, the first topical application of the enchinocandin class of anti-fungals, for the treatment of vulvovaginal candidiasis, or vvc. in addition, we have developed a proprietary immunotherapy technology platform, cloudbreak™, which we use to create compounds designed to direct a patient’s immune cells to attack and eliminate pathogens that cause infectious disease. we are developing our first cloudbreak development candidate, c001, for the treatment of invasive aspergillosis.
Organization
Cidara Therapeutics
Employees
69
CEO
Dr. Jeffrey L. Stein Ph.D.
Industry
Health Technology

Management People of Cidara Therapeutics

NameTitle
Dr. Jeffrey L. Stein Ph.D.
President, CEO & Executive Director
Mr. Shane M. Ward
COO & Corporate Secretary
Dr. Taylor Sandison M.D., M.P.H.
Chief Medical Officer
Dr. Kevin M. Forrest Ph.D.
Founder & Chief Strategy Officer
Dr. Preetam Shah M.B.A., Ph.D.
CFO & Principal Accounting Officer
Ms. Allison Lewis CCP, SPHR
Senior Vice President of People & Culture
Dr. Leslie Tari Ph.D.
Chief Scientific Officer
Dr. Nicole Davarpanah J.D., M.D.
Senior VP of Translational Research & Development
Mr. Jim Beitel M.B.A.
Chief Business Officer

Important FAQs about investing in Cidara Therapeutics from India :

What is Cidara Therapeutics share price today?

Cidara Therapeutics share price today stands at $26.88, Open: $25.61 ; Previous Close: $25.25 ; High: $27.39 ; Low: $25.18 ; 52 Week High: $27.44 ; 52 Week Low: $10.00. The stock opens at $25.61, after a previous close of $25.25. The stock reached a daily high of $27.39 and a low of $25.18, with a 52-week high of $27.44 and a 52-week low of $10.00.

Can Indians buy Cidara Therapeutics shares?

Yes, Indians can invest in the Cidara Therapeutics (CDTX) from India.

With INDmoney, you can buy Cidara Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cidara Therapeutics at zero transaction cost.

How can I buy Cidara Therapeutics shares from India?

It is very easy to buy Cidara Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cidara Therapeutics be purchased?

Yes, you can buy fractional shares of Cidara Therapeutics with INDmoney app.

What are the documents required to start investing in Cidara Therapeutics stocks?

To start investing in Cidara Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cidara Therapeutics

Today’s highest price of Cidara Therapeutics (CDTX) is $27.39.

Today’s lowest price of Cidara Therapeutics (CDTX) is $25.18.

What is today's market capitalisation of Cidara Therapeutics

Today's market capitalisation of Cidara Therapeutics CDTX is 294.2M

What is the 52 Week High and Low Range of Cidara Therapeutics

  • 52 Week High

    $27.44

  • 52 Week Low

    $10.00

What are the historical returns of Cidara Therapeutics?

  • 1 Month Returns

    51.78%

  • 3 Months Returns

    123.07%

  • 1 Year Returns

    71.58%

  • 5 Years Returns

    -62.87%

Who is the Chief Executive Officer (CEO) of Cidara Therapeutics

Dr. Jeffrey L. Stein Ph.D. is the current Chief Executive Officer (CEO) of Cidara Therapeutics.